Spontaneous bacterial and fungal infections in genetically engineered mice: Is Escherichia coli an emerging pathogen

Insights

Genetically engineered mice are susceptible to opportunistic infections, with Escherichia coli emerging as a potential pathogen. Monitoring E. coli is crucial for laboratory mouse welfare and research integrity.

Area of Science:

  • Veterinary Pathology
  • Microbiology
  • Genetically Engineered Models

Background:

  • Genetically engineered (GE) mice are vital research models, but their susceptibility to infections can impact welfare and experimental outcomes.
  • The interplay between host genotype, environment, and microbial pathogens influences disease manifestation in GE mice.

Purpose of the Study:

  • To investigate the bacterial and fungal causes of spontaneous clinical disease in GE mice.
  • To correlate infectious aetiologies with specific mouse genotypes and identify emerging pathogens.

Main Methods:

  • Necropsy and microbiological analysis of 63 GE mice from 33 strains exhibiting clinical signs leading to euthanasia.
  • Identification and quantification of bacterial and fungal pathogens, including Escherichia coli, Pasteurella pneumotropica, Staphylococcus aureus, Enterobacter cloacae, and Pneumocystis murina.

Main Results:

  • Escherichia coli (47.72%) and Pasteurella pneumotropica (43.18%) were the most frequent bacterial causes of infection.
  • Abscesses, pneumonia, endometritis, and septicaemia were common clinical presentations.
  • Pneumocystis murina caused 19 cases of interstitial pneumonia.
  • Bacterial infections occurred in GE mice without explicit immunodeficiency (36.36%).

Conclusions:

  • GE mice, irrespective of genetic modification, are susceptible to opportunistic infections.
  • Escherichia coli should be monitored as a potential emerging pathogen in laboratory mice, alongside traditional opportunists like P. pneumotropica and S. aureus.